Back to top
more

VAREX IMAGING (VREX)

(Delayed Data from NSDQ)

$13.66 USD

13.66
477,596

-0.26 (-1.87%)

Updated Nov 14, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

ResMed (RMD)-Backed Landmark ALASKA Study Favors PAP Therapy

by Zacks Equity Research

A late-breaking abstract from ResMed (RMD) supported landmark ALASKA study reported that treatment with PAP therapy improves the likelihood of longevity in sleep apnea patients

Smith+Nephew (SNN) Releases New Features for Hip Arthroplasty

by Zacks Equity Research

Smith+Nephew (SNN) introduced the RI.HIP NAVIGATION software on the CORI Surgical System and announced the commercial availability of RI.INSIGHTS at the AAOS 2021 Annual Meeting.

Earnings Estimates Moving Higher for VAREX IMAGING (VREX): Time to Buy?

by Zacks Equity Research

VAREX IMAGING (VREX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Here's Why You Should Retain Haemonetics (HAE) Stock for Now

by Zacks Equity Research

Strong recovery across businesses and strength in plasma franchise benefited Haemonetics (HAE) during the first quarter of fiscal 2022.

Zimmer Biomet's (ZBH) Data Favors mymobility with Apple Watch

by Zacks Equity Research

Zimmer Biomet (ZBH) presented four data presentations backing the mymobility with Apple Watch platform at the AAOS 2021 Annual Meeting.

The Zacks Analyst Blog Highlights: Varex Imaging, Omnicell, STAAR Surgical and IDEXX Laboratories

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Varex Imaging, Omnicell, STAAR Surgical and IDEXX Laboratories

Urmimala Biswas headshot

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

by Urmimala Biswas

Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.

Cardiovascular Systems (CSII) Introduces Diamondback in Canada

by Zacks Equity Research

The introduction of Cardiovascular Systems' (CSII) Diamondback 360 Coronary OAS in Canada will offer physicians an effective treatment option for patients with coronary artery diseases.

Medtronic (MDT) Receives FDA Nod for Evolut FX TAVR System

by Zacks Equity Research

Medtronic's (MDT) Evolut FX TAVR system offers hemodynamic and durability benefits of the Evolut platform with new product and procedure enhancements.

Zimmer Biomet (ZBH) Receives FDA Nod for ROSA Hip System

by Zacks Equity Research

The recent FDA go-ahead for Zimmer Biomet's (ZBH) ROSA Hip System will aid surgeons perform robotically-assisted direct anterior total hip replacement surgery.

Hill-Rom (HRC) PSS Growth Solid Despite Tough Y/Y Comparison

by Zacks Equity Research

Hill-Rom's (HRC) recent launches, including the Helion Integrated Surgical System in the United States, buoy optimism.

Abbott (ABT) Receives FDA Nod for Amplatzer Amulet Device

by Zacks Equity Research

The FDA's go-ahead for Abbott's (ABT) Amulet will offer a unique treatment option in the United States that seals off the left atrial appendage entirely without any blood-thinning drugs.

Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It?

by Zacks Equity Research

Strong performance across the Life Science and Clinical Diagnostics businesses drove the top line for Bio-Rad (BIO).

Quest Diagnostics (DGX), eMed Deal to Boost BinaxNOW Sales

by Zacks Equity Research

Under the collaboration, eMed's Certified Guide will supervise Quest Diagnostics' (DGX) BinaxNOW home testing process virtually.

Here's Why You Should Retain Neogen (NEOG) Stock for Now

by Zacks Equity Research

Strong fiscal fourth-quarter performance in the Food Safety and Animal Safety segments drove the top line for Neogen (NEOG).

VAREX IMAGING (VREX) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 48.15% and 2.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VAREX IMAGING (VREX) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 94.44% and 8.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights include: Varex Imaging, Steel Dynamics, EnPro Industries, Dropbox and National Energy

by Zacks Equity Research

Zacks.com featured highlights include: Varex Imaging, Steel Dynamics, EnPro Industries, Dropbox and National Energy

Tirthankar Chakraborty headshot

5 Top Stocks to Buy for Superb Earnings Acceleration

by Tirthankar Chakraborty

Steel Dynamics (STLD), EnPro Industries (NPO) & Dropbox (DBX) are a few stocks for which the last two quarter-over-quarter percentage EPS growth rates exceeded the growth rates of the previous periods.

Varex Imaging's (VREX) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Varex Imaging (VREX).

VAREX IMAGING (VREX) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 300.00% and 2.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate VAREX IMAGING (VREX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rimmi Singhi headshot

Keep These 4 Toxic Stocks Away From Your Portfolio

by Rimmi Singhi

Just like selecting good and undervalued stocks on a regular basis can make you rich, identifying and proactively getting rid of toxic stocks is also crucial to maximizing portfolio returns.

Zacks.com featured highlights include: Aramark, Alteryx, Varex Imaging Corp and Cameco Corp

by Zacks Equity Research

Zacks.com featured highlights include: Aramark, Alteryx, Varex Imaging Corp and Cameco Corp